Cost-Effectiveness of Ceftolozane/Tazobactam as Empiric Therapy for the Treatment of Complicated Urinary Tract Infections in Colombia
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1056
https://www.valueinhealthjournal.com/article/S1098-3015(18)31359-7/fulltext
Title :
Cost-Effectiveness of Ceftolozane/Tazobactam as Empiric Therapy for the Treatment of Complicated Urinary Tract Infections in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31359-7&doi=10.1016/j.jval.2018.04.1056
First page :
Section Title :
Open access? :
No
Section Order :
324